首页> 外文期刊>Digestive Diseases and Sciences >Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan? to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
【24h】

Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan? to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

机译:Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan? to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background Non-invasive tests are widely used to diagnose fibrosis in patients with non-alcoholic fatty liver disease (NAFLD), however, the optimal method remains unclear. We compared the accuracy of simple serum models, a serum model incorporating direct measures of fibrogenesis (Hepascore), and Fibroscan?, for detecting fibrosis in NAFLD.Methods NAFLD patients undergoing liver biopsy were evaluated with Hepascore, NAFLD Fibrosis Score (NFS), FIB-4 and AST-platelet ratio index (APRI), with a subset (n?=?131) undergoing Fibroscan?. Fibrosis on liver biopsy was categorized as advanced (F3–4) or cirrhosis (F4). Accuracy was determined by area under receiving operating characteristic curves (AUC). Indeterminate ranges were calculated using published cut-offs.Results In 271 NAFLD patients, 83 (31) had F3–4 and 47 (17) cirrhosis. 6/131 (4) had an unreliable Fibroscan?. For the detection of advanced fibrosis, the accuracy of Hepascore (AUC 0.88) was higher than FIB-4 (0.73), NFS (0.72) and APRI (0.69) (p?

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号